It is my time, Mr. Taylor.
I'd like to follow up on the issue of collaboration with you, Dr. Mossman, and potentially with you, Mr. Taylor.
I was most interested in hearing what you had to say.
Dr. Nemer told us that, in her view or to her knowledge, there were some 200 vaccines under potential development in Canada, so the task force had a mammoth task, presumably, to filter through all these and look at clinical data and so on.
Would you not see collaboration between proponents, academia and manufacturing facilities as a way forward, and could you elaborate on how that might be operationalized?